Juan A. Martell

MDE Adoption in Industry: Challenges and Success Criteria

Miguel A. Fernández, Wasif Gilani, Parastoo Mohagheghi, 2009, MoDELS.

Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial

Juan A. Martell, T. Crombet, M. Catalá, 2013, BMC Cancer.

Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy.

Juan A. Martell, E. Ruíz-García, M. Ramos-Suzarte, 2012, Cancer biology & therapy.

Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy.

Juan A. Martell, E. Ruíz-García, M. Ramos-Suzarte, 2012, Cancer biology & therapy.